Article
Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia.
Redox biology - 1 Oct 2017
Sun Xiaolei, Zhu Hong, Dong Zhen, Liu Xiangwei, Ma Xin, Han Shasha, Lu Fei, Wang Peng, Qian Sanli, Wang Cong, Shen Cheng, Zhao Xiaona, Zou Yunzeng, Ge Junbo, Sun Aijun
Abstract excerpt
The autologous ALDH bright (ALDHbr) cell therapy for ischemic injury is clinically safe and effective, while the underlying mechanism remains elusive. Here, we demonstrated that the glycolysis dominant metabolism of ALDHbr cells is permissive to restore blood flow in an ischemic hind limb model compared with bone marrow mononuclear cells (BMNCs). PCR array analysis showed overtly elevated Aldh2 expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
